Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cv Sciences Inc (OP: CVSI ) 0.0525 -0.0015 (-2.78%) Streaming Delayed Price Updated: 3:59 PM EDT, Jul 24, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Cv Sciences Inc < Previous 1 2 3 4 5 6 7 Next > Why Is CV Sciences Stock Up Today? November 14, 2022 CV Sciences (OTCQB: CVSI) shares were trading 10.69% higher at $0.044 per share at the time of writing Monday morning on company's third-quarter financial results. Via Benzinga Biden's Pardon For Cannabis Offenders: 27 Reactions From Politicians, Industry Executives And Advocacy Orgs October 07, 2022 President Joe Biden announced on Thursday that he will pardon all prior federal offenses for simple marijuana possession, sending Via Benzinga The CBD Gold Rush Is Over (And That's A Great Thing For Consumers) August 24, 2022 By Bharat Ayyar Disclaimer: I am not a financial advisor. Nothing contained in this post should be construed as investment advice. CV Sciences (OTC: CVSI), the company behind +PlusCBD, had a meteoric... Via Benzinga Marijuana As An Appetite Suppressant? It's A Possibility June 30, 2022 Using cannabis as an appetite suppressant for weight management may seem counterintuitive, but one rare cannabinoid may have just that effect. Delta-9 (d-9)-dominant tetrahydrocannabivarin (THCV) has... Via Benzinga CV Sciences Q1 Revenue Down 8.33%, CEO Encouraged As PlusCBD Brand Gains Market Share May 16, 2022 CV Sciences, Inc. (OTCQB: CVSI) released its financial results for the quarter ended March 31, 2022, revealing a revenue drop of 8.33% to $4.4 million YoY. First Quarter 2022 and Recent Financial and... Via Benzinga CV Sciences Adds +PlusCBD Relief Softgels To Wellness Line Of CBD Products March 08, 2022 CV Sciences, Inc. (OTCQB:CVSI) added +PlusCBD ... Via Benzinga Nutrition Giant GNC To Distribute CBD Products In 770 Stores In US January 06, 2022 Hemp cannabidiol (CBD) products maker CV Sciences, Inc. (OTCQB: Via Benzinga A Preview Of CV Sciences's Earnings March 30, 2022 CV Sciences (OTC:CVSI) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that CV Sciences will... Via Benzinga Dry January Got You Down? Cannabis To The Rescue With Tokes, Yummy Gummies And More January 11, 2022 After the hustle and bustle of the holidays, many people are looking to curtail their consumption of alcohol and are therefore partaking in Via Benzinga CV Sciences Launches +PlusCBD Pain Relief Topicals With Products For Athletes, Arthritis Patients January 11, 2022 CV Sciences, Inc. (OTCQB:CVSI) is launching +PlusCB... Via Benzinga Is Medical Marijuana Really A Slippery Slope? CVSI Distribution Agreement with GNC January 05, 2022 The Best Daily Overview Of The Cannabis Space CV Sciences Announces New Distribution Agreement with GNC. $CVSI ... Via Benzinga Trending Up: $TLLTF $VRNOF $UNRV, GOP Cannabis Bill, Cause for Hope? — Cannabis Daily November 16, 2021 November 16, 2021 The Best Daily Overview Of The Cannabis Space Representativ... Via Benzinga Topics Cannabis Exposures Cannabis The Week In Cannabis: Stocks Down, Republican Legalization Bill, Germany, Uruguay, Earnings, New ETF And More November 19, 2021 Below is a recap of the main news related to the cannabis industry and markets for the week of November 15, 2021. Via Benzinga Topics Cannabis Exposures Cannabis CV Sciences 3Q Financials Continue To Improve Cost Structure, Praises California CBD Legislation November 15, 2021 CV Sciences, Inc. (OTCQB:CVSI), a supplier and manufacturer... Via Benzinga Topics Supply Chain Exposures Supply Chain Earnings Preview For CV Sciences November 12, 2021 CV Sciences (OTC:CVSI) is set to give its latest quarterly earnings report on Monday, 2021-11-15. Here's what investors need to know before the announcement. Analysts estimate... Via Benzinga EXCLUSIVE: CV Sciences Launches New Product Line Featuring Full Range Of Phytocannabinoids October 15, 2021 CV Sciences Inc (OTC:CVSI) is launching a ne... Via Benzinga Looking Into CV Sciences's Return On Capital Employed October 01, 2021 CV Sciences (OTC:CVSI) brought in sales totaling $5.13 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 12.75%, resulting in a loss of $3.... Via Benzinga Ryder Cup To Retirees: Many Golfers Say CBD Is A Hole In One For Their Game September 17, 2021 Professional golf is one of, if not the most cannabis-friendly globally played sports today. While Olympians and athletes in other sports cont... Via Benzinga Cantor Remains Neutral on Charlotte's Web, cbdMD and CV Science CBD Stocks, Sector Could Benefit From Federal Legalization August 13, 2021 Cantor Fitzgerald released a new report analyzing the possible effects of CBD reform in the stock performance of Charlotte... Via Benzinga American Cannabis Operator Index Lost 0.6% This Year, Best Players In July: Columbia Care, Lowell Farms, Ayr Wellness & Ascend Wellness August 02, 2021 The American Cannabis Operator Index declined for the fifth straight month falling 10.7% to 62.66. The index, which launched in Oc... Via Benzinga Topics Cannabis Exposures Cannabis Slight Correction For Cannabis Stocks After A Ramping Week, Check Out The Top Movers For July 30, 2021 July 30, 2021 GAINERS: Rhinomed (OTC: Via Benzinga Topics Cannabis Exposures Cannabis The Week In Cannabis: Amazon Lobbies In DC, Colombia's New Law, Big IPOs And More July 23, 2021 Below is a recap of the main news related to the cannabis industry and markets for the week of July 16, 2021. Via Benzinga Topics Cannabis Exposures Cannabis Watch Planet 13's CEO & Matt Hawkins From Entourage Effect Capital At Benzinga Cannabis Hour 7/21 July 23, 2021 Benzinga’s Cannabis Hour is a live show for cannabis investors. On Thursday's show, hosts Elliot L... Via Benzinga Topics Cannabis Exposures Cannabis CBD Can Reduce Nicotine Withdrawal Symptoms, Says New Study Done By CV Sciences July 22, 2021 This week, CV Sciences (OTCQB:CVSI) released the results of... Via Benzinga Australis, CV Sciences And MedMen Among Top Cannabis Stock Movers On July 9, 2021 July 09, 2021 GAINERS: Livewell Canada Inc (OTC: Via Benzinga Topics Cannabis Exposures Cannabis Watch CV Sciences & Lyphe Group On The Benzinga Cannabis Hour July 08, 2021 Benzinga’s Cannabis Hour is a live show for cannabis investors. On Thursday’s show, hosts Elliot Lane... Via Benzinga Topics Cannabis Exposures Cannabis Cannabis Stock Gainers And Losers From June 21, 2021 June 21, 2021 GAINERS: Mexco Energy (AMEX: Via Benzinga Topics Cannabis Exposures Cannabis Cantor Updates Ratings On Several Cannabis And CBD Stocks - MedMen, Jushi, cbdMD, CV Sciences June 18, 2021 Cantor Fitzgerald’s Pablo Zuanic provided updated ratings and estimates on several stocks from the cannabis and CBD sector, those being ... Via Benzinga Topics Cannabis Exposures Cannabis Cannabis Stock Gainers And Losers From June 15, 2021 June 15, 2021 GAINERS: Invictus MD Strategies (OT... Via Benzinga Topics Cannabis Exposures Cannabis Cannabis Stock Gainers And Losers From June 11, 2021 June 11, 2021 GAINERS: CURE Pharmaceutical Hldg (O... Via Benzinga Topics Cannabis Exposures Cannabis < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.